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WNK1 andWNK4mutations have been reported
to cause pseudohypoaldosteronism type II
(PHAII), an autosomal-dominant disorder char-
acterized by hyperkalemia and hypertension.
To elucidate the molecular pathophysiology
of PHAII, we generated Wnk4D561A/+ knockin
mice presenting the phenotypes of PHAII. The
knockin mice showed increased apical expres-
sion of phosphorylated Na-Cl cotransporter
(NCC) in the distal convoluted tubules. In-
creased phosphorylation of the kinases OSR1
and SPAK was also observed in the knockin
mice. Apical localization of the ROMK potas-
sium channel and transepithelial Cl permeabil-
ity in the cortical collecting ducts were not
affected in the knockin mice, whereas activity
of epithelial Na+ channels (ENaC) was in-
creased. This increase, however, was not evi-
dent after hydrochlorothiazide treatment, sug-
gesting that the regulation of ENaC was not
a genetic but a secondary effect. Thus, the path-
ogenesis of PHAII caused by a missense muta-
tion of WNK4 was identified to be increased
function of NCC through activation of the
OSR1/SPAK-NCC phosphorylation cascade.
INTRODUCTION
Hypertension is one of the most common diseases in the
industrialized world, occurring in approximately 20%–
25% of general populations. Studies of monogenetic
hypertensive diseases such as pseudohypoaldosteron-
ism type II (PHAII) (Achard et al., 2001), an autosomal-
dominant disorder characterized by hyperkalemia andCelhypertension (Schambelan et al., 1981; Gordon 1986),
would help us obtain insight into a number of mechanisms
underlying blood pressure regulation in a more common
and polygenic form of hypertension, so-called essential
hypertension. Hypertension in PHAII has been postulated
to be caused by an increase in Na+ reabsorption through
gain of function of the thiazide-sensitive Na-Cl cotrans-
porter (NCC) (Mayan et al., 2004). Dysfunction of renal
K+ channels and increased Cl reabsorption through
a paracellular pathway are also thought to be involved in
the pathophysiology of PHAII (Schambelan et al., 1981;
Take et al., 1991). Recently, mutations in the with-no-
lysine kinase 1 (WNK1) and WNK4 genes, which encode
unusual serine/threonine kinases with catalytic domain
sequences containing cysteine in place of a lysine con-
served in the subdomain II of most kinases (Verissimo
and Jordan, 2001), were shown to cause PHAII (Wilson
et al., 2001). These findings provided us with the impetus
to investigate a new signaling pathway regulating NaCl
and K+ transport in the kidney.
Initially, three out of four WNK4 mutations (E562K,
D564A, and Q565E) reported to cause PHAII were found
clustered in a negatively charged segment distal to the
first coil domain of WNK4 (Wilson et al., 2001). This seg-
ment is highly conserved among all members of the
WNK family in humans, mice, and rats, suggesting that
these clustered mutations may have a common patho-
genic effect. Consistent with this hypothesis, paracellular
Cl permeability has been shown to be increased by all
three of these PHAII-causing WNK4 mutants in polarized
Madin-Darby canine kidney (MDCK) cells (Yamauchi
et al., 2004; Kahle et al., 2004). However, effect on plasma
membrane expression of NCC was inconsistent in these
mutants. Wild-type WNK4 inhibited plasma membrane
expression of NCC in Xenopus oocytes (Wilson et al.,
2003; Yang et al., 2003) and MDCK cells (Yang et al.,
2005). Since the mouse Q562E Wnk4 (equivalent to hu-
man Q565E) lost this inhibitory effect, loss of function in
this mutant was thought to cause increased NCCl Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc. 331
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Wnk4D561A/+ Knockin Mouseexpression in PHAII patients. On the other hand, unlike
Q562E in mouse, D561A in mouse and D564A in human
WNK4 retain the inhibitory effect as well as the wild-type
WNK4 in both oocytes and MDCK cells (Wilson et al.,
2003; Yang et al., 2003, 2005), thus calling into question
the claim that the loss of inhibitory function of NCC in mu-
tant WNK4 is the pathogenesis of PHAII. As for the renal
K+ channel, reduced membrane expression of ROMK
(renal outer medullary K+) by mouse Q562E Wnk4 was
observed in oocytes (Kahle et al., 2004), whereas ClC-
Kb gene promoter-driven D564A Wnk4 transgenic mice
did not show a change of apical expression of ROMK in
distal renal tubules (Yamauchi et al., 2005). Thus, the
effects of mutant WNK4 on membrane expression of
NCC and ROMK were not consistent, possibly due to
overexpression in heterologous expression systems.
Thus, in order to determine the controversial effects of
mutant WNK4 on these target molecules, generation and
analysis of a true animal model was necessary. Very re-
cently, Lifton’s group (Lalioti et al., 2006) successfully gen-
erated mutant Q562E Wnk4 transgenic mice that repro-
duce the human phenotypes of PHAII. They also showed
that PHAII phenotypes disappeared when the mice were
crossed with Ncc null mice. Accordingly, this transgenic
approach indicated that PHAII phenotypes were caused
by NCC through gain of function of the mutant WNK4.
However, this is inconsistent with the results of the same
group’s previous study on NCC and WNK4 in oocytes
(Wilson et al., 2003). As such, how NCC is involved in
the disease remains unknown for these transgenic mice.
In addition, there are inherent problems in using a trans-
genic approach to analyze the pathogenesis of a disease
with even dominant inheritance. For example, transcrip-
tion from a transgene may not necessarily be the same
as that from the native gene, even if the copy number of
the transgene is adjusted to ensure two copies. At the
same time, it is impossible to avoid an increase in the total
number of the gene of interest, which is a situation differ-
ent from that in the patients. Also, some phenotypes, even
in a disease with dominant inheritance, can actually be
due to haploinsufficiency. Given these considerations,
we chose to adopt a gene knockin strategy rather than
a transgenic strategy and successfully generated a mutant
Wnk4 knockin mouse as an appropriate mouse model of
PHAII. A detailed and comprehensive analysis of these
Wnk4D561A/+ knockin mice clarified the pathogenesis of
PHAII.
RESULTS
Generation of Wnk4D561A/+ Knockin Mice
To generate Wnk4D561A/+ knockin mice, we used homolo-
gous recombination in embryonic stem (ES) cells to create
a mutant allele in which exon 7 of the Wnk4 gene was
replaced by a cassette expressing the selective marker
neomycin transferase followed by the mutant exon 7
(D561A) (Figure 1A). Three recombinant ES cells were
found to be Wnk4flox/+. We crossed chimeric mice from
two clones (L39 and K2) with C57BL/6 mice to produce332 Cell Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc.mutant Wnk4flox/+ progeny (Figure 1A). The generation of
mutant Wnk4flox/+ mice was verified by PCR (Figure 1B).
Additional Southern blot analysis was used to verify the
results of PCR (Figure 1C). The neo cassette was then
deleted by crossing the mutant Wnk4flox/+ mice with Cre
recombinase-expressing transgenic mice (Sakai and
Miyazaki, 1997) (Figure 1A). The Cre-mediated excision
of the neo cassette was verified by PCR, as shown in
Figure 1D. The phenotypes described below were not sig-
nificantly different in the two Wnk4D561A/+ knockin mouse
lines (L39 and K2). Sequencing RT-PCR products from
exon 7, where the missense mutation is located, showed
that Wnk4 mRNAs were transcribed from both the wild-
type and the D561A allele in the Wnk4D561A/+ knockin
mice (Figure 1E), and total Wnk4 protein level in the
knockin mice was not significantly affected (Figure 1F).
Localization of Wnk4 protein in the heterozygous knockin
mice appeared to be similar to that in Wnk4+/+ wild-type
mice: Wnk4 mainly resided at the subapical plasma mem-
branes and tight junctions in distal convoluted tubules
(DCT) and in the intracellular region in cortical collecting
ducts (CCD), as previously reported (Wilson et al., 2001)
(Figure 1G).
Phenotypes of theWnk4D561A/+ Knockin Mice
We observed no obvious differences between Wnk4+/+
and Wnk4D561A/+ mice in survival, gross physical appear-
ance, and organ morphology for one year. When
compared to Wnk4+/+ littermate mice, the Wnk4D561A/+
mice began to show mild hyperkalemia (blood [K+] =
3.9 ± 0.3 mmol/l in Wnk4+/+ versus 4.2 ± 0.4 mmol/l in
Wnk4D561A/+; p < 0.05, n = 7) at the age of 1.5 months.
Then, at 3.5 months, significant hypertension (systolic
blood pressure = 119.6 ± 6.6 mm Hg in Wnk4+/+ versus
142.3 ± 9.1 mm Hg in Wnk4D561A/+; p < 0.01, n = 12), met-
abolic acidosis (veinous blood pH = 7.31 ± 0.05 inWnk4+/+
versus 7.26 ± 0.04 in Wnk4D561A/+; p < 0.05, n = 12; blood
[HCO3
] = 23.6 ± 1.4 mmol/l in Wnk4+/+ versus 19.9 ±
1.5 mmol/l in Wnk4D561A/+; p < 0.001, n = 12), and hyper-
kalemia (blood [K+] = 4.0 ± 0.3 mmol/l in Wnk4+/+ versus
4.9 ± 0.5 mmol/l in Wnk4D561A/+; p < 0.01, n = 12) with
low fractional excretion of K+ (FEK) in urine (11.9% ±
1.5% in Wnk4+/+ versus 9.1% ± 2.8% in Wnk4D561A/+;
p < 0.05, n = 12) were observed in the Wnk4D561A/+
mice, showing successful establishment of PHAII model
mice. These blood pressure and blood biochemistry ab-
normalities were partially and completely corrected by in-
traperitoneal injection of 5 mg/kg/day and 50 mg/kg/day
of hydrochlorothiazide (HCTZ), respectively (Table 1).
Blood pressure measurements for mice on low- versus
high-NaCl diet are shown in Figure S1 in the Supplemental
Data available with this article online.
Increased OSR1/SPAK and NCC Phosphorylation
Cascade in Wnk4D561A/+ Mice
We first focused on the expression and localization of
NCC since the disease phenotypes were corrected by thi-
azide treatment. Western blot of NCC using total lysates
and membrane fractions from kidneys revealed that the
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Wnk4D561A/+ Knockin MouseFigure 1. Generation ofWnk4D561A/+ Knockin Mice
(A) Targeting strategy for generating Wnk4D561A/+ knockin mice. The diagram shows the wild-type Wnk4 locus, the targeting construct, and the
targeted locus before and after Cre recombination.
(B) Verification of homologous recombination by PCR of genomic DNA of the selected ES cell clones; primers F1 and R1 were as shown in (A). The
6.2 kb band is from the mutated allele. The primer set was designed not to amplify the wild-type Wnk4 gene. K2 and L39 are names of ES clones. W,
host ES cells.
(C) Verification of homologous recombination by Southern blotting of EcoRI-digested genomic DNA derived from mouse tails. The 5.2 kb band is from
the wild-type allele, and the 4.1 kb band is from the mutated allele.
(D) Genotyping PCR after Cre recombination using a primer set (F2 and R2) flanking the remaining loxP site. The 320 bp band represents the mutant
allele containing the remaining loxP site, while the 370 bp band represents the wild-type allele.
(E) Direct sequencing of the RT-PCR product covering the mutation site. Kidney mRNA was isolated from Wnk4D561A/+ knockin mice, and cDNA
corresponding to exon 7 was amplified by PCR and sequenced.
(F) Immunoblot of Wnk4 from Wnk4+/+ (W) and Wnk4D561A/+ (H) mice and its semiquantification by densitometry analysis. Total protein (10 mg) was
applied in each lane, and equal loading was verified by silver staining. Wnk4 protein abundance in the two groups was not significantly different
(p = 0.064).
(G) Immunofluorescence of Wnk4 in the cortex of Wnk4+/+ (W) and Wnk4D561A/+ (H) mice. Scale bars = 10 mm.NCC protein level was elevated in the Wnk4D561A/+ mice
(Figure 2A). Immunofluorescence of NCC and AQP2
(Figure 2B, upper panels) showed no appreciable change
in NCC distribution along nephron segments. However,
under higher magnification (Figure 2B, lower panel),
NCC immunofluorescence appeared to be more con-
densed in the apical membranes in Wnk4D561A/+ mice
than in Wnk4+/+ mice, and the luminal surface area of
some NCC-positive segments also appeared to be in-
creased in Wnk4D561A/+ mice. To confirm this more quan-
titatively, immunoelectron microscopy was performed
(Figure 2C). The number of gold particles on the apicalCeplasma membranes as well as in the cytoplasm was
counted. As shown in Figure 2D, the number of total
gold particles per mm2 of cell area, and in the apical
plasma membranes per mm of apical membrane, was
significantly higher in the Wnk4D561A/+ mice.
It has been reported that the Ste20-related kinases
OSR1 (oxidative stress response kinase 1) and SPAK
(Ste20-related proline alanine-rich kinase) are down-
stream targets of WNK kinases (Moriguchi et al., 2005;
Vitari et al., 2005, 2006; Anselmo et al., 2006). OSR1 and
SPAK are known to phosphorylate NCC (Moriguchi
et al., 2005) and Na-K-2Cl cotransporter 1 (NKCC1)ll Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc. 333
Table 1. Blood P
days) (2.5 mg/kg; twice daily)
0) H (n = 11) p
Blood Pressure (m
Systolic .5 128.8 ± 7.6* <0.001
Diastolic .7 74.1 ± 11.7* 0.009
Blood
Na+ (mmol/l) .6 151.4 ± 1.7 0.100
K+ (mmol/l) .3 4.6 ± 0.2* <0.001
Cl (mmol/l) .1 119.4 ± 2.0* 0.006
pH (veinous) .02 7.27 ± 0.05* <0.001
HCO3
 (mmol/l) .3 21.7 ± 1.5* 0.007
BUN (mg/dl) .9 20.8 ± 5.3 0.218
Creatinine (mg/d .07 0.33 ± 0.09 0.452
Aldosterone (pg/
PRA (ng/ml/hr)
Urine
FENa (%)
FEK (%)
FECl (%)
W, Wnk4+/+; H, Wn Cl, respectively. *p < 0.05.
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eressure and Blood and Urine Biochemistries ofWnk4+/+ andWnk4D561A/+Mice
Basal HCTZ (3 hr) (25 mg/kg; bolus) HCTZ (5 days) (25 mg/kg; twice daily) HCTZ (7
W (n = 12) H (n = 12) p W (n = 12) H (n = 12) p W (n = 10) H (n = 10) p W (n = 1
m Hg)
119.6 ± 6.6 142.3 ± 9.1* 0.006 118.4 ± 6.0 117.6 ± 2.5 0.556 117.3 ± 4
71.2 ± 16.4 84.6 ± 13.5 0.282 60.1 ± 13.7 60.8 ± 13.1 0.927 62.7 ± 4
145.1 ± 1.8 144.3 ± 1.8 0.425 141.5 ± 2.2 136.2 ± 3.8* 0.005 145.4 ± 3.7 148.1 ± 1.7 0.082 150.2 ± 1
4.0 ± 0.3 4.9 ± 0.5* 0.002 3.8 ± 0.4 3.5 ± 0.4 0.268 3.8 ± 0.4 3.9 ± 0.3 0.842 3.9 ± 1
111.0 ± 1.8 114.2 ± 1.5* 0.002 107.4 ± 2.6 103.1 ± 3.1* 0.011 112.6 ± 3.4 115.7 ± 3.4 0.098 115.9 ± 3
7.31 ± 0.05 7.26 ± 0.04* 0.048 7.30 ± 0.04 7.32 ± 0.06 0.19 7.31 ± 0.04 7.30 ± 0.06 0.918 7.30 ± 0
23.6 ± 1.4 19.9 ± 1.5 <0.001 24.4 ± 2.8 24.6 ± 1.7 0.917 23.7 ± 2.6 22.6 ± 1.4 0.316 23.6 ± 1
21.7 ± 3.1 20.5 ± 6.9 0.65 24.3 ± 7.0 23.8 ± 5.6 0.902 24.4 ± 3.8 26.6 ± 5.6 0.65 18.4 ± 2
l) 0.25 ± 0.06 0.26 ± 0.08 0.943 0.34 ± 0.05 0.33 ± 0.07 0.876 0.31 ± 0.06 0.29 ± 0.06 0.445 0.35 ± 0
ml) 215 ± 108 266 ± 146 0.475 362 ± 190 715 ± 310 0.049
17.4 ± 7.4 5.2 ± 2.3* <0.001
0.44 ± 0.06 0.41 ± 0.05 0.479 0.41 ± 0.14 0.51 ± 0.23 0.254
11.9 ± 1.5 9.1 ± 2.8* 0.028 15.5 ± 5.0 24.1 ± 11.5 0.062
0.69 ± 0.12 0.61 ± 0.18 0.32 0.54 ± 0.18 0.69 ± 0.10 0.173
k4D561A/+. BUN, blood urea nitrogen; PRA, plasma renin activity. FENa, FEK, and FECl represent fractional excretion of Na
+, K+, and
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Wnk4D561A/+ Knockin Mouse(Gagnon et al., 2006a), and phosphorylation of NCC was
also recently identified as increasing NCC transport activ-
ity (Pacheco-Alvarez, et al., 2006). We examined whether
this signal transduction pathway was involved in PHAII
pathogenesis. As shown in Figure 3A, phosphorylated
(p-) OSR1/SPAK expression was significantly increased
in the Wnk4D561A/+ mice without a concomitant increase
in total OSR1/SPAK abundance. We further focused on
the phosphorylation of NCC by generating an antibody
recognizing p-NCC on Ser71, one of the potential sites
of NCC phosphorylation by WNK4 (Moriguchi et al.,
2005). Even after total NCC protein levels from the
Wnk4+/+ and Wnk4D561A/+ mice were adjusted by the im-
munoblot results, phosphorylation of NCC on Ser71 was
increased in theWnk4D561A/+ mice (Figure 3B). Immunoflu-
orescence of p-NCC (Figure 3C) showed that p-NCC was
much more abundant in the Wnk4D561A/+ mice. The differ-
ence was also clearly recognized in immunogold labeling
of p-NCC (Figure 3D), though a statistical comparison
was not performed. (The signal of p-NCC in Wnk4+/+
mice was almost zero.) Furthermore, p-NCC immunofluo-
rescence appeared to be highly localized to the apical
membranes compared with total NCC immunofluores-
cence. Under the same sampling conditions (see Experi-
mental Procedures) as used in the immunogold labeling
of total NCC (Figure 2D), the ratio of the number of gold
particles in the apical membranes to the total particles
in the cells in the Wnk4D561A/+ mice was 82% ± 12%
(mean ± SD, n = 20), which was significantly higher than
the value (52% ± 8%, mean ± SD, n = 20) when the anti-
body to total NCC was used (p < 0.01). These results
strongly suggest that the phosphorylation of NCC is
important for apical localization.
Increased ENaC and Maxi-K Expression instead
of ROMK1 inWnk4D561A/+ Mice
Next, we investigated the involvement of epithelial Na+
channels (ENaC) and ROMK1, two important channels
for Na+ reabsorption and K+ secretion in CCD, in the path-
ogenesis of PHAII. The protein levels of both ENaC(a) and
(b) were elevated inWnk4D561A/+ mice (Figure 4A). ENaC(b)
immunofluorescence results were consistent with those of
the western blot (Figure 4B), and the luminal surface area
appeared to be increased in Wnk4D561A/+, similar to the
results observed for DCT. In particular, the level of apical
staining of ENaC(b) appeared to be much higher. As pre-
viously observed in low-salt-fed and aldosterone-treated
rats (Ergonul et al., 2006), increases of the 30 kDa frag-
ment of ENaC(a) and the 70 kDa band of ENaC(g) were
also seen in the Wnk4D561A/+ mice (Figure 4A), also sup-
porting the activation of ENaC. On the other hand, the total
protein level (Figure 4A) and immunofluorescence of
ROMK1 (Figure 4B) were unchanged in the Wnk4D561A/+
mice compared to wild-type mice. Immunogold labeling
confirmed that there was apical membrane expression
of ROMK1 in CCD of the Wnk4D561A/+ mice (Figure 4C).
Finally, we examined the expression of maxi-K channel,
another K+ channel in CCD involved in K+ secretion. AnCeelevated level of maxi-K(a) protein was found in
Wnk4D561A/+ mice (Figure 4A).
Mechanism of Hyperkalemia in Wnk4D561A/+ Mice
Since the total and apical expression of ROMK1 did not
decrease, as postulated previously (Kahle et al., 2003),
while maxi-K increased in Wnk4D561A/+ mice, we investi-
gated K+ excretion in Wnk4D561A/+ mice. Wnk4+/+ and
Wnk4D561A/+ mice were injected intraperitoneally with 2 ml
of 0.9% NaCl or 1.5% Na2SO4. As shown in Figure 5A
(left panel), 0.9% NaCl infusion slightly increased FEK
from 12.6% ± 1.6% to 14.6% ± 3.8% (at 1 hr; p < 0.05,
n = 12) in Wnk4+/+ mice. In Wnk4D561A/+ mice, however,
no such increase in FEK, but rather a decrease, was
observed (pre, 9.1% ± 2.8%; 1 hr post, 7.5% ± 2.2%;
n = 12) (Figure 5A, left panel). On the other hand, Na2SO4
(a sodium salt that is not transported by NCC) infusion
increased FEK not only in Wnk4
+/+ mice (pre, 9.5% ± 3.3%;
1 hr post, 22.8% ± 5.3%; n = 12) but also in Wnk4D561A/+
mice (pre, 8.8% ± 2.3%; 1 hr post, 57.2% ± 5.3%; n =
12) (Figure 5A, middle panel). This increase in FEK by
Na2SO4 infusion was quite similar to that produced by
hydrochlorothiazide treatment (Figure 5A, right panel),
and the magnitude of the increase was much higher in
Wnk4D561A/+ mice than Wnk4+/+ mice (p < 0.01). At the
same time, serum K+ and HCO3
 concentrations were cor-
rected (blood [K+] = 3.5 ± 0.7 mmol/l in Wnk4+/+ versus
3.0 ± 0.5 mmol/l inWnk4D561A/+ 1 hr after Na2SO4 infusion;
blood [HCO3
] = 25.6 ± 2.4 mmol/l in Wnk4+/+ versus
24.1 ± 1.1 mmol/l in Wnk4D561A/+ 1 hr after Na2SO4 infu-
sion). These responses to sodium salts in the Wnk4+/+
andWnk4D561A/+ mice were similar to those in normal sub-
jects and PHAII patients (Schambelan et al., 1981; Take
et al., 1991), suggesting that a NaCl-specific transport
system is activated, and the potassium excretion system
itself is preserved or even activated, in Wnk4D561A/+
mice. Thus, reduced availability of NaCl in CCD, due to
increased reabsorption through NCC in DCT, decreased
K+ secretion in CCD in Wnk4D561A/+ mice (see below).
In Vitro Microperfusion of CCD
We next performed a second functional analysis of
sodium and chloride transport in CCD using an in vitro
microperfusion technique. In the steady-state condition,
transepithelial voltage (VT) in Wnk4
+/+ and Wnk4D561A/+
mice was 1.7 ± 0.7 and 3.8 ± 0.7 mV, respectively
(Figure 5B), a statistically significant difference (p < 0.05,
n = 8). This difference disappeared when 10 mM amiloride
was added to the lumen (+0.5 ± 0.5 mV in Wnk4+/+, +1.0 ±
0.7 mV in Wnk4D561A/+; not significant, n = 8), suggesting
that the difference in VT in the steady-state condition
may be caused by increased activity of ENaC in the
Wnk4D561A/+ mice. In the presence of amiloride, we ob-
served a shift of VT to positive values, which reflected ac-
tive K+ excretion into the lumen of CCD. It also suggested
that the K+ excretion system in CCD was not perturbed in
Wnk4D561A/+ mice. Next, we measured the Cl/Na+ per-
meability ratio (PCl/PNa) in CCD. In the basal condition,
PCl/PNa was 1.49 ± 0.12 and 1.11 ± 0.07 in the Wnk4
+/+ll Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc. 335
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Wnk4D561A/+ Knockin MouseFigure 2. Regulation of NCC in Wnk4D561A/+ Mice
(A) Immunoblotting of NCC using whole lysates and crude membrane fractions from Wnk4+/+ (W) andWnk4D561A/+ (H) mouse kidneys, and their semi-
quantification by densitometry analysis. Total protein (10 mg) was applied in each lane and verified by silver staining. NCC was significantly increased
in Wnk4D561A/+ mice (whole lysate, *p < 0.001; crude membrane fractions, *p < 0.001).
(B) Double immunofluorescence of NCC (green) and AQP2 (red) in cortex under low magnification (upper panels) and higher magnification of NCC
(lower panels). Scale bars = 100 mm in upper panels, 10 mm in lower panels.336 Cell Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc.
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Wnk4D561A/+ Knockin MouseFigure 3. Increased Phosphorylation of NCC and OSR1/SPAK inWnk4D561A/+ Mice
(A) Phosphorylation of OSR1/SPAK. Total protein (10 mg) fromWnk4+/+ (W) andWnk4D561A/+ (H) mice was applied in each lane, and equal loading was
verified by silver staining. The expression of total and phosphorylated (p)-OSR1/SPAK was checked by anti-OSR1/SPAK and anti-p-OSR1/SPAK
antibodies, respectively. A semiquantification was also performed by densitometry analysis (p-SPAK, *p = 0.047; p-OSR1, *p < 0.001; SPAK,
p = 0.758; OSR1, p = 0.443).
(B) Phosphorylation of NCC. Total amount of NCC in whole lysates (lower panel) fromWnk4+/+ (W) andWnk4D561A/+ (H) mice was adjusted to be nearly
equal by immunoblot using anti-NCC antibody. Under this condition, p-NCC level was compared using phosphospecific p-NCC antibody on Ser71
(upper panel). A densitometry analysis was performed on the immunoblot of p-NCC (*p < 0.001).
(C) Immunofluorescence of p-NCC. Compared with the immunofluorescence of total NCC as seen in Figure 2B, the difference in signals between
Wnk4+/+ (W) and Wnk4D561A/+ (H) mice is more evident. Scale bars = 20 mm.
(D) Immunogold labeling of p-NCC inWnk4+/+ (W) andWnk4D561A/+ (H) mice. Increased apical p-NCC was observed inWnk4D561A/+ (H) mice (315000).and Wnk4D561A/+ mice, respectively (Figure 5C). These
values were significantly different (p < 0.02, n = 8). As ob-
served with the change in VT, the difference in PCl/PNa also
disappeared when 10 mM amiloride was added to the
lumen (1.63 ± 0.13 in Wnk4+/+ versus 1.39 ± 0.04 in
Wnk4D561A/+; not significant, n = 8). These results indi-
cated that transepithelial Na+ permeability through ENaC
rather than Cl permeability was increased in CCD of
the Wnk4D561A/+ mice, consistent with the ENaC immuno-
blot and immunofluorescence results (Figures 4A and 4B).
Chronic Effect of Hydrochlorothiazide on NCC,
ENaC, and Maxi-K inWnk4D561A/+ Mice
Finally, we examined the chronic effect of HCTZ (25 mg/kg
intraperitoneally, twice daily for 5 days) on the above-
mentioned ion channels and transporter in distal nephrons
by immunoblot and immunofluorescence studies. All of
the NCC, ENaC, and maxi-K channels showed increasesafter HCTZ treatment in the wild-type mice (Figure S2A),consistent with a previous report (Na et al., 2003). Differ-
ences observed between Wnk4D561A/+ and Wnk4+/+ mice
before HCTZ treatment (higher levels inWnk4D561A/+ com-
pared to Wnk4+/+) were not evident for ENaC(a), ENaC(b),
and maxi-K after HCTZ treatment but still existed for NCC
(Figure S2A). Similar results were also obtained by immu-
nofluorescence. Apical expression of NCC in Wnk4D561A/+
mice was still higher compared to Wnk4+/+ mice after
HCTZ treatment, whereas apical ENaC(b) expression
was lower (Figures S2B and S2C).
DISCUSSION
The Wnk4D561A/+ mice generated in this study initially pre-
sented hyperkalemia and subsequently developed meta-
bolic acidosis and hypertension like PHAII patients
(Mayan et al., 2004). Since the total protein level of Wnk4
in kidney and its cellular localization in distal nephrons
are not significantly different between Wnk4+/+ and(C) Immunogold labeling of NCC. Arrow indicates the cellular localization of NCC (315,000) in distal convoluted tubules.
(D) Quantification of immunogold labeling of NCC. Total and apical NCC signals in Wnk4+/+ (W) and Wnk4D561A/+ (H) mice are shown. Twenty pictures
in each group were analyzed; *p < 0.01. In this and all other figures, error bars represent ±SD.Cell Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc. 337
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Wnk4D561A/+ Knockin MouseFigure 4. Regulation of ENaC, ROMK1, and Maxi-K Channels inWnk4D561A/+ Mice
(A) Immunoblotting of ENaC, ROMK1, and maxi-K using whole-lysate fractions of Wnk4+/+ (W) and Wnk4D561A/+ (H) mouse kidneys. Total protein
(10 mg) was applied in each lane and verified by silver staining. Densitometry analysis was performed on each immunoblot (ROMK1, p = 0.584;
maxi-K, p = 0.002; ENaC(a) (85 kDa), *p = 0.009; ENaC(a) (35 kDa), *p = 0.032; ENaC(b), *p = 0.017; ENaC(g) (85 kDa), *p = 0.033; ENaC(g)
(70 kDa), *p = 0.01).
(B) Double immunofluorescence of ENaC(b) and ROMK1 (red in top panels) in cortex with calbindin D28K (a marker for DCT2, CNT, and CCD; shown in
green in middle panels). Scale bars = 10 mm in panels at left, 20 mm in panels at right.
(C) Immunogold labeling (320,000) of ROMK1 in the apical membrane areas in CCD. Arrows indicate the apical membrane localization of ROMK1
in CCD.338 Cell Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc.
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Wnk4D561A/+ Knockin MouseFigure 5. Physiological Analysis of
Wnk4D561A/+ Mice
(A)FEK is a fractional excretion of K
+, which is
K+ clearance expressed as a percentage of
creatinine clearance. *p < 0.01 between
Wnk4+/+ (W,C) and Wnk4D561A/+ (H,-) mice.
(B) Transepithelial voltage (VT) of CCD. VT is
significantly lower in Wnk4D561A/+ (H) mice
than in Wnk4+/+ (W) mice (*p < 0.05), but the
difference disappeared in the presence of
amiloride.
(C) Cl/Na+ permeability ratio (PCl/PNa) in the
CCD. PCl/PNa is significantly lower in
Wnk4D561A/+ (H) mice than in Wnk4+/+ (W)
mice (*p < 0.02), but the difference disap-
peared in the presence of amiloride.Wnk4D561A/+ mice, altered function of the mutant WNK4,
rather than either change in total amount of WNK4 protein
or aberrant intracellular sorting of WNK4, may be respon-
sible for the pathogenesis of PHAII. Because the dis-
ease-causing mutations are clustered at the position just
distal to the first coiled-coil domain rather than in the ki-
nase domain, it has been speculated that the function of
WNK4 may be altered by these mutations through chang-
ing the interaction (or interactions) with one or more un-
known proteins at the mutation sites. Although little was
known about signaling pathways involving WNK kinase, in-
creasing evidence, including ours (Moriguchi et al., 2005),
has recently shown that OSR1 and SPAK, two similar ser-Cine/threonine kinases belonging to the germinal center-like
kinase subfamily VI (also called Ste20-related kinases), are
important downstream targets of WNK kinases (Vitari et al.,
2005, 2006; Anselmo et al., 2006). WNK1 and 4 directly
bind to OSR1 and SPAK and phosphorylate their evolu-
tionarily conserved threonine and serine residues (Thr185
and Ser325 in OSR1, and Ser380 in SPAK) in vitro (Morigu-
chi et al., 2005; Vitari et al., 2005; Anselmo et al., 2006).
Also, these STE20-related kinases have been confirmed
to phosphorylate Slc12 cation/chloride cotransporters
such as NKCC1 and NCC in vitro (Moriguchi et al., 2005;
Gagnon et al., 2006a). Phosphorylation of these conserved
threonine and serine residues in the amino-terminal tails ofell Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc. 339
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Wnk4D561A/+ Knockin MouseNKCC1 and NCC has been shown to increase their trans-
port activity (Gagnon et al., 2006b; Pacheco-Alvarez, et al.,
2006). Thus, it is conceivable that the mutant WNK4 en-
hances this signaling pathway, thereby activating NCC.
However, we found no report in the literature that directly
proves this hypothesis. In fact, we were unable to even de-
tect an increase in OSR1 phosphorylation by mutant
WNK4 in MDCK cells (data not shown). However, in this
mouse model, we could clearly observe the increased
phosphorylation of both OSR1/SPAK and NCC. As for
NCC, we confirmed increased phosphorylation on Ser71
in Wnk4D561A/+ mice, consistent with our previous in vitro
study (Moriguchi et al., 2005). This constitutes direct evi-
dence showing the involvement of the WNK4-OSR1/
SPAK-NCC signal transduction pathway in the pathogen-
esis of PHAII. The reason that we could not reconstitute
this activation in MDCK cells may be that one or more other
interacting proteins may be missing in the cultured cell line.
At present, it is not known whether the mutant WNK4 itself
is an activator for OSR1/SPAK or whether the wild-type
WNK4 is a repressor for OSR1/SPAK and the mutant
WNK4 loses the inhibitory effect. To directly answer this
question, Wnk4 null mice are needed.
Phosphorylation of NCC in low-chloride medium in Xen-
opus oocytes has shown that phosphorylation increases
NCC transport activity without affecting the expression
in plasma membranes (Pacheco-Alvarez, et al., 2006).
Based on this observation, transport activity of NCC in
Wnk4D561A/+ mice must be activated, since p-NCC is
much more abundant in apical plasma membranes in
Wnk4D561A/+ mice than in wild-type mice (Figures 3C and
3D). Phosphorylation of NCC might extend the half-life of
NCC in the apical membranes and/or regulate its transloc-
alization to apical membranes. Transient overexpression
systems using oocytes might miss such an effect
(Pacheco-Alvarez, et al., 2006). Along with the increased
p-NCC in the apical membranes, we did observe lower
FENa in Wnk4
D561A/+ mice after 0.9% NaCl infusion
(0.97% ± 0.36% and 0.55% ± 0.29% in Wnk4+/+ and
Wnk4D561A/+mice, respectively; p < 0.05, n = 12) with lower
FEK (Figure 5A). In addition, an increase in apical surface
area in DCT, as reported for Q562E Wnk4 transgenic
mice (Lalioti et al., 2006), was also observed in the
Wnk4D561A/+ mice. These data suggest that high Na+
reabsorption via NCC does occur in vivo. We also have
been attempting in vitro microperfusion of DCT; however,
we have not yet obtained robust data because micro-
perfusing DCT is far more technically difficult than micro-
perfusing CCD.
In addition to NCC, we also found an increase in
ENaC(a) and ENaC(b) protein expression in the kidneys
of WNK4D561A/+ mice (Figure 4A). Although immunogold
labeling was unsuccessful in ENaC, immunofluorescence
and in vitro microperfusion of CCD clearly showed that
ENaC activity in the apical membranes of CCD was
activated in Wnk4D561A/+ mice. Whether this is a primary
abnormality or a secondary mechanism that compensates
for reduced luminal Na+ availability in CCD and/or hyper-
kalemia remains undetermined. Recently, Aaron et al.340 Cell Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc(2007) reported increased amiloride-sensitive Na+ trans-
port in the distal colon of PHAII transgenic mice, suggest-
ing that ENaC is activated by a gain-of-function effect of
the mutant WNK4. In our Wnk4D561A/+ mice, however, af-
ter correction of the PHAII phenotypes by chronic thiazide
treatment (Table 1), phenotypes resembling Liddle’s
syndrome, especially hypokalemia, never appeared there-
after. There was also no significant difference in ENaC
expression between Wnk4+/+ and Wnk4D561A/+ mice after
HCTZ treatment (Figures S2A and S2C). This suggests
that ENaC activation is a secondary effect. Even so, we
also observed an increase in luminal surface area in
ENaC(b)- and AQP2-positive cortical nephron segments
(Figure 4B and Figure S2C), as well as in DCT. A previous
study also showed that ENaC-expressing cells appear
hypertrophy prone when rats are bred under conditions
of NaCl restriction (Nielsen et al., 2002). Low luminal
sodium concentration in CCD in Wnk4D561A/+ mice may
mimic the conditions of NaCl restriction, though the exact
mechanism is unknown.
ROMK, an important K+ channel for renal K+ secretion
in CCD, has also been postulated to be involved in the
pathogenesis of PHAII, especially with respect to hyper-
kalemia. Kahle et al. (2003) reported that a disease-
causing Wnk4 mutant, Q562E, strongly inhibited ROMK
surface expression in oocytes. On the other hand, there
was no change in cellular localization of ROMK in distal
nephrons of D564A and Q562E Wnk4 transgenic mice
(Yamauchi et al., 2005; Lalioti et al., 2006). In our knockin
mouse model, no changes in protein abundance or intra-
cellular distribution of ROMK were observed. These
results suggest that ROMK may not be a direct target
molecule of WNK4. Maxi-K channel, a flow-stimulated
and relatively quiescent K+ channel in the basal state, is
also proposed to be involved in the pathogenesis of
hyperkalemia in PHAII (Xie et al., 2006). We checked the
protein level of maxi-K(a) by immunoblot in Wnk4D561A/+
mice and found that it was not decreased, but rather
increased, in Wnk4D561A/+ mice. This increase was not
evident after chronic thiazide treatment (Figure S2A),
suggesting that maxi-K increase in Wnk4D561A/+ mice
may act as a compensatory mechanism. Similar compen-
satory increase of maxi-K channel was reported in Romk-
deficient or high-potassium-adapted wild-type mice
(Bailey et al., 2006). Accordingly, we conclude that the
mechanism of hyperkalemia in PHAII is a decrease in
electrogenic Na+ reabsorption in CCD caused by consti-
tutive overreabsorption of NaCl via NCC (Figure 6A).
Na+ (ENaC) and K+ (ROMK and maxi-K) channels them-
selves are not directly involved in the pathogenesis of
hyperkalemia. Increased ENaC expression along with
a lack of decrease in expression of both ROMK and
maxi-K might nicely explain the exaggerated acute
potassium excretion in Wnk4D561A/+ mice caused by
Na2SO4 infusion and thiazide treatment (Figure 5A and
Figure 6B).
Finally, we also analyzed whether the paracellular Cl
permeability in CCD was increased in Wnk4D561A/+ mice
using in vitro CCD microperfusion, since Kahle et al..
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Wnk4D561A/+ Knockin MouseFigure 6. Na+ and K+ Transport in Distal
Convoluted Tubules and Cortical Col-
lecting Ducts in Normal and PHAII Mice
(A) In the normal state, Na+ reabsorption oc-
curs via NCC and ENaC, and K+ is secreted
mainly by ROMK. In the PHA II state, NaCl re-
absorption is increased by overexpressed
NCC in DCT, which causes low luminal Na+
concentration in the CCD ([Na+]CCD) and in-
hibits K+ secretion via ROMK. The low [Na+]CCD
and hyperkalemia may consequently stimulate
ENaC and maxi-K expression.
(B) In the PHA II state, NaCl infusion does not
increase the [Na+]CCD and K
+ secretion be-
cause infused NaCl is still mainly reabsorbed
by overexpressed NCC in DCT. On the other
hand, when [Na+]CCD and CCD flow are in-
creased by inhibiting Na+ reabsorption via
NCC through Na2SO4 or hydrochlorothiazide
(HCTZ) infusion, Na+ reabsorption and K+ se-
cretion in CCD occur via ENaC and ROMK, re-
spectively. Maxi-K channel might also play
a role in K+ secretion in this situation.(2004) and our group (Yamauchi et al., 2004) previously
reported that expression of disease-causing mutant
WNK4 increased paracellular Cl permeability in MDCK
cells. Although direct measurement of Cl permeability
using tracer flux could not be performed due to technical
difficulties, the data on the ratio of Cl to Na+ permeability
and VT before and after amiloride treatment strongly
suggested that there might not be a robust increase in
transepithelial Cl permeability in Wnk4D561A/+ mice. In-
stead of Cl permeability, Na+ permeability via ENaC
appears to have been increased, which is consistent
with our immunoblot and immunofluorescence studies of
ENaC. Also, evidence that the transepithelial voltage
shifted to positive voltage after amiloride treatment, and
the lack of difference between Wnk4+/+ mice and
Wnk4D561A/+ mice, suggests that the K+-secreting path-
way (possibly ROMK) itself is unaffected in Wnk4D561A/+
mice.In summary, this comprehensive analysis of
Wnk4D561A/+ mice, an appropriate mouse model of PHAII,
clarifies the overall molecular pathogenesis of PHAII and
establishes the idea that the WNK4-OSR1/SPAK-NCC
pathway is a powerful signaling cascade that regulates
blood pressure and electrolyte homeostasis in the kidney.
This PHAII mouse model also serves as an appropriate
model for developing new antihypertensive agents modu-
lating WNK function and its signal transduction pathway.
EXPERIMENTAL PROCEDURES
Generation ofWnk4561A/+ Knockin Mice
To generate Wnk4561A/+ knockin mice, the targeting vector was pre-
pared using PCR-amplified segments of theWnk4 gene in which entire
sequences were verified by sequencing. The point mutation (D561A)
was introduced into exon 7 of the targeting vector by site-directed
mutagenesis (Stratagene). The targeting vector was then transfected
into J1 ES cells by electroporation (Sohara et al., 2006). After selectionCell Metabolism 5, 331–344, May 2007 ª2007 Elsevier Inc. 341
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Wnk4D561A/+ Knockin Mousewith 150 mg/ml G418 and 2 mM ganciclovir, ES clones targeted
correctly were selected by PCR (primers: F1, 50-GCTCATTCCTCC
CACTCATGA-30; R1, 50-CTAAGTGTGTGTCTTGTGCCA-30), Southern
blotting, and sequencing of the mutation site and then injected into
C57BL/6 blastocysts. Chimeric males were bred with C57BL/6
females to produce mutant Wnk4flox/+ (D561A) mice, and the neo cas-
sette was then deleted by crossing these mutant Wnk4flox/+ mice with
Cre recombinase-expressing transgenic mice (Sakai and Miyazaki,
1997). The genotype of mutant Wnk4D561A/+ mice was verified by
PCR (primers: F2, 50-AGGCCTCGAACTCAGAGACTG-30; R2, 50-
TGCTGCACCAAGCATAAAGCA-30), and the mice were subsequently
crossed with a C57BL/6 background.
Blood and Urine Analysis and Blood Pressure Measurement
Wnk4+/+ and Wnk4D561A/+ mice were fed a normal diet (0.4% Na+ [w/
w]; 0.8% K+: [w/w]) and plain drinking water ad libitum for 12–16 weeks.
The blood pressure of restrained conscious mice at a steady state was
measured by a programmable tail-cuff sphygmomanometer (MK-
2000A, Muromachi) (Iwamoto et al., 2004). Blood was drawn from
the retro-orbital sinus under light ether anesthesia. Mice were kept in
metabolic cages for urine collection. Serum data were determined
by i-STAT. Serum aldosterone levels and plasma renin activity were
measured by the SRL clinical laboratory service (Tokyo). Urine sam-
ples were analyzed by DRI-CHEM (Fujifilm).
Assessment of the Effects of Hydrochlorothiazide, Saline,
and Na2SO4 Infusion on K
+ Excretion
HCTZ (Sigma) was injected intraperitoneally. Preliminary titration ex-
periments were performed to determine the dose of HCTZ needed to
induce acute sodium excretion. A dose of 0.25 mg/kg did not, but
2.5 mg/kg did, increase sodium excretion within 4 hr after the intra-
peritoneal injection in the wild-type mice. A dose of 2.5 mg/kg twice
daily (5 mg/kg/day) was initially adopted for the chronic experi-
ment since the natriuretic effect was not sustained for 24 hr when
HCTZ was injected intraperitoneally. Two milliliters of 0.9% saline or
1.5% Na2SO4 was injected intraperitoneally into Wnk4
+/+ and
Wnk4D561A/+ mice. Urine and blood samples were collected hourly
for 3 consecutive hr.
Immunoblotting, Immunofluorescence, and Immunogold
Electron Microscopy
Semiquantitative immunoblotting was carried out as described (Wang
et al., 2001) to assess relative expression levels of proteins of interest
using whole homogenate without nuclear fraction (600 3 g) or crude
membrane fraction (17,000 3 g) from whole kidneys. The intensity of
bands was analyzed using ImageGauge software (Fujifilm). For immu-
nofluorescence and immunogold electron microscopy, kidneys were
fixed by perfusion (through the left ventricle) with periodate lysine
(0.2 M) and paraformaldehyde (2%) in PBS. Tissue samples were
soaked for several hours in 20% sucrose in PBS, embedded in Tis-
sue-Tek OCT Compound (Sakura Finetechnical Co., Ltd.), and snap
frozen in liquid nitrogen. The primary antibodies used were as follows:
rabbit anti-WNK4 (1:200) (Alpha Diagnostic), rabbit anti-NCC (1:200)
(Chemicon), rabbit anti-ROMK1 (1:200) (Alomone), rabbit anti-maxi-K
(1:100) (Alomone), rabbit anti-ENaC(b) (1:200) (Alomone), mouse anti-
calbindin-D28K (1:10,000) (Swant), and goat anti-AQP2 (1:200) (Santa
Cruz). Rabbit anti-ENaC(a) and rabbit anti-ENaC(g) were generous
gifts from M.A. Knepper (National Institutes of Health) (Masilamani
et al., 1999). When appropriate, antibody specificity was verified by
antigen absorption test (Figure S3).
Alkaline-phosphatase-conjugated anti-IgG antibodies (Promega)
were used as secondary antibodies for immunoblotting, and Alexa
488 or 546 dye-labeled (Molecular Probes) secondary antibodies
were used for immunofluorescence. Immunofluorescence images
were obtained by LSM510 Meta (Carl Zeiss). Immunogold labeling
was performed as described previously (Sohara et al., 2006), and elec-
tron microscopy images were obtained using Hitachi H7000 electron
microscopy. The semiquantification of immunogold signals was per-342 Cell Metabolism 5, 331–344, May 2007 ª2007 Elsevier Incformed as described by Neilsen and coworkers (Promeneur et al.,
2000). Briefly, >50 pictures of cells were taken by an individual blinded
to the genotype of three pairs of Wnk4+/+ and Wnk4D561A/+ mice. We
then chose at least six pictures per mouse (total number of pictures
was 20 for each genotype) with >10 particles per cell, again blinded
to the genotype of the sample. The cytoplasmic area (excluding nuclei)
and apical membrane length were measured by ImageJ software
(http://rsb.info.nih.gov/ij/). To ensure that the quantification was per-
formed on comparable tissue sampling, the cytoplasmic area was
divided by the apical membrane length. These values in Wnk4+/+ and
Wnk4D561A/+ mice turned out to not be significantly different: 3.5 ±
0.2 and 3.4 ± 0.3 mm (mean ± SD, n = 20), respectively. Data of total
number of particles in cells and particles on the apical membranes
are presented as a function of cytoplasmic area and apical membrane
length, respectively.
Phosphorylation Status of OSR1/SPAK and NCC in Kidneys
ofWnk4D561A/+ Mice
Whole homogenates were prepared in lysis buffer containing phos-
phatase inhibitor as described (Moriguchi et al., 2005). Total and
phosphorylated (p-) OSR1/SPAK were determined by rabbit anti-
OSR1/SPAK and rabbit anti-p-OSR1(Ser325)/SPAK(Ser380) anti-
bodies (Moriguchi et al., 2005), respectively. We also generated an
antibody to specifically recognize p-NCC on Ser71 by immunizing
rabbits with a keyhole limpet hemocyanin-conjugated synthetic
phosphopeptide corresponding to residues 67–75 of mouse NCC
(HYANpSALPG). The serum was affinity purified with the antigen phos-
phopeptide and then immunoabsorbed against the corresponding
nonphosphopeptide. When appropriate, antibody specificity was
verified by antigen absorption test (Figure S3).
In Vitro Microperfusion of the Cortical Collecting Duct
For the microperfusion study, the CCD was microdissected and micro-
perfused in vitro on an inverted microscope as described (Matsumura
et al., 1999). During the preincubation period, we microperfused both
sides of the CCD with the same bicarbonate-buffered solution contain-
ing NaCl (115 mmol/l), Na acetate (1 mmol/l), KCl (3 mmol/l), KH2PO4
(2 mmol/l), CaCl2 (1.5 mmol/l), MgCl2 (1 mmol/l), L-alanine (5 mmol/l),
glucose (5.5 mmol/l), and NaHCO3 (25 mmol/l) gassed with 95% O2/
5%CO2 and titrated to pH 7.4. Cl
/Na+ permeability ratios (PCl/PNa)
were determined from the measurement of the diffusional potential
at zero volume flow produced by transepithelial ion activity gradients
according to the Goldman equation,
VT = 2:3ð½R3T=FÞ3 logð½abNa + ðPCl=PNaÞalCl=½alNa + ðPCl=PNaÞabClÞ;
where PCl and PNa are the permeability of the epithelium to Cl
 and
Na+, respectively, and R, T, and F have their usual meanings. When
the diffusional potential for NaCl was measured, the concentration of
NaCl in the bath was reduced by 65 mM by replacing NaCl with
equimolar urea.
Statistical Analysis
Results obtained for the Wnk4D561A/+ knockin mice were compared
with those for the wild-type mice by Student’s t test or, if the data
violated a normal distribution, by nonparametric Mann-Whitney test.
Data are presented as mean ± SD. p < 0.05 was considered statisti-
cally significant (indicated by *).
Supplemental Data
Supplemental Data include three figures and can be found with this
article online at http://www.cellmetabolism.org/cgi/content/full/5/5/
331/DC1/.
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